Air Liquide Announces a Major Healthcare Acquisition in Japan

26-Sep-2017 Intellasia | BusinessWire | 10:35 PM Print This Post

PARIS–(BUSINESS WIRE)–Regulatory News:

Air Liquide (Paris:AI) is expanding its healthcare business in Japan
with the acquisition of Sogo Sangyo Kabushiki Kaisha (“SSKK”), a major
Japanese player with a strong presence in the home healthcare and
medical gases markets especially in the Tokyo region.

Present in the Japanese market for 60 years, SSKK is specialized in the medical
gases field serving more than 2000 hospitals and clinics
and home
for patients suffering from respiratory diseases including:
sleep apnea, Chronic Obstructive Pulmonary Disease and chronic
respiratory failure. This acquisition represents a major
development of the Healthcare activity locally where it increases the
number of patients served at home by Air Liquide in Japan to
reach 20,000

Well known for its medical staffs’ know-how, SSKK has more than 150
and generated revenue of approximately €27 million in
Air Liquide will rely on the commitment of the teams in place
to pursue the development of SSKK business.

Worldwide, Japan now ranks as the third-largest Respiratory Home
Healthcare market
after the US and France. Home Healthcare
services in Japan
are expected to continue increasing, supported
by a robust healthcare system and social welfare coverage reaching
almost 100% of the population.

With this acquisition, Air Liquide strengthens its footprint in Japan
both in medical gases to hospitals and in home healthcare business.

François Jackow, member of the Air Liquide Group’s Executive
Committee, supervising the Healthcare activities, said: “With this
acquisition Air Liquide pursues the development of its Healthcare
activity in a growing Asian market that benefits from a strong
potential. We are delighted to welcome SSKK’s teams in Air Liquide
Group. Thanks to their know-how combined with Air Liquide expertise, we
will deliver greater value to healthcare professionals and patients.
This acquisition, which allows us to develop our activities in Japan,
will also fuel our future growth”.

Air Liquide Healthcare
Liquide supplies medical gases, home healthcare services, hygiene
products, medical equipment and specialty ingredients. In 2016, it
served over 15,000 hospitals and clinics and more than 1.4 million
patients at home throughout the world. The Group’s Healthcare business
reached €3,111 million in revenues in 2016, with the support of its
15,000 employees.

Air Liquide in Japan
established in 1907 in Japan, Air Liquide now serves 15,000 customers
across the country, particularly in Electronics, thanks to its 2,000
employees. The Group also has a Research and Technology Centre in
Tsukuba (near Tokyo) and an Engineering center in Kobe. Japan serves as
a technology & research base for Air Liquide in Asia and beyond.


The world leader in gases, technologies and services for Industry and
Health, Air Liquide is present in 80 countries with approximately 65,000
employees and serves more than 3 million customers and patients. Oxygen,
nitrogen and hydrogen are essential small molecules for life, matter and
energy. They embody Air Liquide’s scientific territory and have been at
the core of the company’s activities since its creation in 1902.

Air Liquide’s ambition is to lead its industry, deliver long term
performance and contribute to sustainability. The company’s
customer-centric transformation strategy aims at profitable growth over
the long term. It relies on operational excellence, selective
investments, open innovation and a network organization implemented by
the Group worldwide. Through the commitment and inventiveness of its
people, Air Liquide leverages energy and environment transition, changes
in healthcare and digitization, and delivers greater value to all its

Air Liquide’s revenue amounted to €18.1 billion in 2016 and its
solutions that protect life and the environment represented more than
40% of sales. Air Liquide is listed on the Euronext Paris stock exchange
(compartment A) and belongs to the CAC 40, EURO STOXX 50 and FTSE4Good
us on Twitter @airliquidegroup


Air Liquide
Corporate Communications
Brugier, +33 (0)1 40 62 50 59
Aurélie Wayser-Langevin, +33
(0)1 40 62 56 19
Investor Relations
(0)1 40 62 50 87
+1 (0) 610 263 8277
Liquide Healthcare Communications

Coralie Gazzeri, +33(0)1 49
69 45 40
Air Liquide Japan Communications
Toyoyama, +81 3 6414 6728


Category: BusinessWire, PRAsia

Print This Post

Comments are closed.